BMS-817399

DB14941InvestigationalSmall molecule

BMS-817399 is under investigation in clinical trial NCT01404585 (Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis).

Mechanism: Pharmacologically active on C-C chemokine receptor type 1
Curator reviewed
Formula / weight: C₂₃H₃₆ClN₃O₄ · 454.01 g/mol (avg)
Code names: BMS-817399

Resolves to

Compound

UNIIAKQ3X6FEH0CAS1202400-18-7ChEMBLCHEMBL3334824

Structure

InChIKeyGTDPZONCGOCXOD-JPYJTQIMSA-NSMILESCC(C)[C@@H](NC(=O)NCC(C)(C)O)C(=O)N1CC[C@](O)(C2=CC=C(Cl)C=C2)C(C)(C)C1

Targets

P32246CCR1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-817399, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account